Rebekka Weber

2.9k total citations · 3 hit papers
16 papers, 2.2k citations indexed

About

Rebekka Weber is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Rebekka Weber has authored 16 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Immunology, 11 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Rebekka Weber's work include Immune cells in cancer (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immune Cell Function and Interaction (4 papers). Rebekka Weber is often cited by papers focused on Immune cells in cancer (12 papers), Cancer Immunotherapy and Biomarkers (6 papers) and Immune Cell Function and Interaction (4 papers). Rebekka Weber collaborates with scholars based in Germany, Israel and Italy. Rebekka Weber's co-authors include Jochen Utikal, Peter Altevogt, Christopher Groth, Xiaoying Hu, Viktor Fleming, Viktor Umansky, Viktor Umansky, Vasyl S. Nagibin, Vera Petrova and Ihor Arkhypov and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and International Journal of Molecular Sciences.

In The Last Decade

Rebekka Weber

16 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression

2018 614 citations Christopher Groth, Xiaoying Hu et al. British Journal of Cancer profile →
Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors

2018 406 citations Rebekka Weber, Viktor Fleming et al. Frontiers in Immunology profile →
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression

2018 355 citations Viktor Fleming, Xiaoying Hu et al. Frontiers in Immunology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rebekka Weber Germany	15	1.6k	1.2k	620	240	190	16	2.2k
Christopher Groth Germany	14	1.5k 0.9×	1.1k 0.9×	584 0.9×	240 1.0×	187 1.0×	18	2.1k
Kim Vrijland Netherlands	12	1.4k 0.9×	1.1k 0.9×	542 0.9×	253 1.1×	187 1.0×	17	2.1k
Alexandra Sevko Germany	19	1.4k 0.9×	1.1k 1.0×	712 1.1×	241 1.0×	126 0.7×	22	2.1k
Viktor Fleming Germany	9	1.3k 0.8×	938 0.8×	459 0.7×	179 0.7×	163 0.9×	10	1.8k
Swetha Anandhan United States	9	899 0.6×	951 0.8×	612 1.0×	202 0.8×	209 1.1×	13	1.8k
Armelle Prévost‐Blondel France	27	1.8k 1.2×	1.4k 1.2×	672 1.1×	253 1.1×	160 0.8×	46	2.7k
Hyun-Il Cho United States	15	1.7k 1.1×	1.1k 0.9×	506 0.8×	312 1.3×	128 0.7×	15	2.2k
Isabel Poschke Germany	27	2.1k 1.3×	1.5k 1.3×	573 0.9×	145 0.6×	106 0.6×	49	2.7k
Eva Van Overmeire Belgium	16	1.3k 0.8×	767 0.7×	582 0.9×	233 1.0×	108 0.6×	20	1.9k
Karen Clise-Dwyer United States	23	1.1k 0.7×	781 0.7×	795 1.3×	359 1.5×	94 0.5×	54	2.2k

Countries citing papers authored by Rebekka Weber

Since Specialization

Citations

This map shows the geographic impact of Rebekka Weber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rebekka Weber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rebekka Weber more than expected).

Fields of papers citing papers by Rebekka Weber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rebekka Weber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rebekka Weber. The network helps show where Rebekka Weber may publish in the future.

Co-authorship network of co-authors of Rebekka Weber

This figure shows the co-authorship network connecting the top 25 collaborators of Rebekka Weber. A scholar is included among the top collaborators of Rebekka Weber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rebekka Weber. Rebekka Weber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Groth, Christopher, Ludovica Arpinati, Merav E. Shaul, et al.. (2021). Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression. Cancers. 13(4). 726–726. 24 indexed citations

Groth, Christopher, Rebekka Weber, Samantha Lasser, et al.. (2021). Tumor promoting capacity of polymorphonuclear myeloid‐derived suppressor cells and their neutralization. International Journal of Cancer. 149(9). 1628–1638. 19 indexed citations

Weber, Rebekka, Christopher Groth, Samantha Lasser, et al.. (2020). IL-6 as a major regulator of MDSC activity and possible target for cancer immunotherapy. Cellular Immunology. 359. 104254–104254. 219 indexed citations

Gebhardt, Christoffer, Rebekka Weber, Raphael Reinhard, et al.. (2020). Potential therapeutic effect of low-dose paclitaxel in melanoma patients resistant to immune checkpoint blockade: A pilot study. Cellular Immunology. 360. 104274–104274. 19 indexed citations

Groth, Christopher, Rebekka Weber, Jochen Utikal, & Viktor Umansky. (2020). Depletion and Maturation of Myeloid-Derived Suppressor Cells in Murine Cancer Models. Methods in molecular biology. 2236. 67–75. 2 indexed citations

Weber, Rebekka, Zeno Riester, Laura Hüser, et al.. (2020). IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma. Journal for ImmunoTherapy of Cancer. 8(2). e000949–e000949. 94 indexed citations

Hu, Xiaoying, Jasper Panten, Simon Renders, et al.. (2020). Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitors. OncoImmunology. 9(1). 1727116–1727116. 57 indexed citations

Petrova, Vera, Ihor Arkhypov, Rebekka Weber, et al.. (2020). Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma. International Journal of Molecular Sciences. 21(7). 2367–2367. 38 indexed citations

Arkhypov, Ihor, Samantha Lasser, Vera Petrova, et al.. (2020). Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles. International Journal of Molecular Sciences. 21(17). 6319–6319. 36 indexed citations

10.

Fleming, Viktor, Xiaoying Hu, Rebekka Weber, et al.. (2019). Melanoma Extracellular Vesicles Generate Immunosuppressive Myeloid Cells by Upregulating PD-L1 via TLR4 Signaling. Cancer Research. 79(18). 4715–4728. 110 indexed citations

11.

Blattner, C, Viktor Fleming, Rebekka Weber, et al.. (2018). CCR5+ Myeloid-Derived Suppressor Cells Are Enriched and Activated in Melanoma Lesions. Cancer Research. 78(1). 157–167. 151 indexed citations

12.

Fleming, Viktor, Xiaoying Hu, Rebekka Weber, et al.. (2018). Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression. Frontiers in Immunology. 9. 398–398. 355 indexed citations breakdown →

13.

Douglas, Ross G., Prajwal P. Nandekar, Hirdesh Kumar, et al.. (2018). Inter-subunit interactions drive divergent dynamics in mammalian and Plasmodium actin filaments. PLoS Biology. 16(7). e2005345–e2005345. 36 indexed citations

14.

Groth, Christopher, Xiaoying Hu, Rebekka Weber, et al.. (2018). Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression. British Journal of Cancer. 120(1). 16–25. 614 indexed citations breakdown →

15.

Weber, Rebekka, Viktor Fleming, Xiaoying Hu, et al.. (2018). Myeloid-Derived Suppressor Cells Hinder the Anti-Cancer Activity of Immune Checkpoint Inhibitors. Frontiers in Immunology. 9. 1310–1310. 406 indexed citations breakdown →

16.

Hersey, Peter, Jeff Sosman, Steven O’Day, et al.. (2005). A phase II, randomized, open-label study evaluating the antitumor activity of MEDI-522, a humanized monoclonal antibody directed against the human alpha v beta 3 (avb3) integrin, ± dacarbazine (DTIC) in patients with metastatic melanoma (MM). Journal of Clinical Oncology. 23(16_suppl). 7507–7507. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact